Bendcare Supports aiSLE™ DX Flare Risk Index Testing Access for Patients with Lupus (SLE)
News provided by
Share this article
OKLAHOMA CITY, April 8, 2021 /PRNewswire/
Progentec, a leader in diagnostic and digital technologies for the proactive management of autoimmune diseases, announced today that Bendcare, a large healthcare services and technology organization which empowers community rheumatologists in the United States, is supporting clinician and patient access to the aiSLE™ DX Flare Risk Index. Bendcare plans to begin offering rheumatologists in the Bendcare and American Arthritis and Rheumatology Associates (AARA) networks clinical education sessions focused on the laboratory technology later this month. Additionally, Progentec will be utilizing Bendcare s Columbus Data Repository to analyze the impact of the aiSLE™ DX Flare Risk Index.